Relaying what matters next.

Astronomers have flagged 2025 PN7 as a newly discovered quasi-moon that closely tracks Earth. Here is how it hid for decades, why its orbit is unusual, and how it could unlock rapid, low-cost missions while sharpening planetary defense.

An inside look at how Citi is moving beyond copilots to production AI agents in banking. We unpack the stack, identity and data guardrails, and the ROI math so CIOs can scale safely in high‑compliance environments.

Australia just shifted Ghost Shark from prototypes to a funded fleet, with the first XL-AUVs planned to enter Royal Australian Navy service in early 2026. Here is how mass autonomy could reshape Indo-Pacific deterrence and how China may respond.

FTX’s third distribution on September 30, 2025 will release about $1.6 billion to creditors. Here is how that cash could travel from BitGo and Kraken into majors, L2s, Solana and TON, and what to watch across spot, perps, bridges, and DeFi yields in the days that follow.

A coalition of PJM-state governors is moving to exert new influence over the nation’s largest grid as AI data centers turbocharge demand and push capacity prices higher. Here is what could change next for rules, rates, interconnection, and resources.

A first-in-human Alzheimer’s study of an oral autophagy enhancer is about to test whether restoring cellular clean-up can slow neurodegeneration. Here is why proteostasis matters, what to watch in the trial, and what a readout could unlock next.

On March 19, 2025, Euclid unveiled its first science trove: 63.1 square degrees and roughly 26 million detections. The images already spotlight strong lenses, rich clusters, and filaments you can explore now, with full DR1 slated for October 2026.

Citi’s September pilot of autonomous agents inside Stylus Workspaces marks a real move from demos to production. See how browser agents and modern orchestration reshape enterprise rollouts, why the agent cost curve matters, and a concrete blueprint with KPIs to ship in Q4 2025.

Israel says its Iron Beam laser will enter service in 2025 after completing final tests in September. A combat ready high energy laser could flip the economics of defending against rockets, mortars, and drones while reshaping tactics and procurement worldwide.

A builder and investor playbook for the next 6 to 18 months under the new U.S. stablecoin law. Deadlines, winners and losers, DeFi yield shifts, exchange liquidity changes, and a clear U.S. vs MiCA roadmap.

Governors across the PJM region are forming a new collaborative to shape grid planning and market rules as AI data center demand drives up capacity prices and reliability risk. Here is what they want to change, how it could hit bills, and the milestones to watch next.

New analyses of Chang'e-6 farside samples suggest mantle water as low as 1 to 1.5 micrograms per gram and basalt ages near 2.83 billion years. The results tighten resource expectations away from mid‑latitudes and sharpen Artemis priorities around polar ice and operations.

On September 19, 2025 the FDA implemented a court-ordered vacatur of its 2024 LDT framework, shifting oversight back to CLIA. Expect faster epigenetic clocks, proteomic age panels, and multi-omic biomarkers in clinics, along with greater variation in quality. Here is what changed and how to judge credibility.

Microsoft, NVIDIA, and OpenAI turned AI agents from demos into deployable systems in 2025. See why they are production ready, a secure reference architecture, real cost and latency tradeoffs, and a pragmatic 30-60-90 day rollout plan.

Unveiled in Lviv on Sept. 19, 2025, the TLK-1000 promises 2,000 km reach and a multi-ton payload. If it scales, autonomous deep-strike UUVs could upend naval strategy and trigger a global race to defend ports, bridges, cables, and fleets.

A quiet SEC rule change replaces one-off approvals with generic listing standards, shrinking crypto ETF timelines from months to weeks. With DOGE and XRP ETFs trading, we break down what this means for liquidity, custody, surveillance, and the road to broader crypto exposure.

Exploding AI data center demand is arriving just as a major wave of US and Qatari LNG supply hits global markets. The cross‑currents are rewriting policy from PJM to ERCOT, reshaping capacity prices, and guiding where new gas plants get built.

Retro Biosciences plans a first-in-human study of RTR242, an autophagy-enhancing pill for Alzheimer’s. Learn why a disease label can accelerate longevity drugs, the biomarker stack to watch through 2026, and how this brain-first strategy compares with partial epigenetic reprogramming.